Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

08:23 ET U-Haul Building New Conference and Fitness Center in Phoenix

U-Haul® International is ready to break ground on a multi-million dollar conference and fitness center, which is set to be the showpiece of its...


08:19 ET HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Global biotherapeutics leader CSL Behring announced today that Hizentra received orphan-drug exclusivity from the U.S. Food and Drug Administration...


08:18 ET The iQ Group Global Appoints World-Renowned Chemist to the Board of Member Company, GBS Inc.

The iQ Group Global, an enterprise dedicated to developing early stage bioscience assets, has made yet another high-profile appointment to the Board...


08:06 ET Eisai Presents New Seizure Freedom and Adherence Data Related to Anti-Epileptic Drug FYCOMPA® at the 2019 American Epilepsy Society Annual Meeting

Eisai Inc. presented new seizure freedom and adherence data related to its antiepileptic drug (AED) FYCOMPA® (perampanel) CIII at the 2019 American...


08:01 ET Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours

Australian life sciences company, QBiotics Group Limited (QBiotics) is today announcing the publication[1] of positive results from a first in-human...


08:00 ET CNS Pharmaceuticals to Participate in the 8th Annual ROTH Deer Valley Corporate Access Event

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for...


08:00 ET HSS Extends Global Network to Colombia with New Collaboration

HSS, the world's leading academic medical center focused on musculoskeletal health headquartered at Hospital for Special Surgery in New York, today...


08:00 ET AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical...


08:00 ET BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors

BJ Bioscience Inc. (the 'company') today announced that the first patient was successfully dosed on December 4, 2019 in the first-in-human (FIH)...


08:00 ET Folium Labs Inc Announces Closing of a New Investment Round and Receives NRC-IRAP Grant from the Government of Canada to Support IP Strategy

TORONTO, Dec. 9, 2019 /PRNewswire/ - Canadian biotechnology company, Folium Labs Inc., gains an undisclosed investment led by YEDI Venture Fund to...


08:00 ET Oracle Health Sciences Participates in TOP Tech Sprint

Clinical trials are an essential gateway for getting new cures to market. However, many patients struggle to find the right trials that meet their...


08:00 ET Hoth Therapeutics And North Carolina State University Initiate Preclinical Gene Therapy Study For The Treatment Of Asthma

Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for...


08:00 ET Windtree to Host a Conference Call on December 11, 2019 to Provide Development Programs and Financial Update

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical...


08:00 ET PDL BioPharma Announces Completion of Strategic Review Process

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced today that it has completed the strategic review process that it initiated in...


08:00 ET 61st ASH Congress 2019: Menarini Ricerche Presents the Latest Updates About the First In Human Clinical Trial of SEL24/MEN1703

Menarini Ricerche is progressing with the clinical development of SEL24/MEN1703, and will be presenting the design of the ongoing First In Human...


08:00 ET Sight Sciences Appoints Erica Rogers to its Board of Directors

Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma...


08:00 ET Efficacy, Durability of Response and Safety of Onvansertib Demonstrated in Completed Phase 1b Trial in AML Patients Presented in Oral Session at ASH

Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division ...


08:00 ET Athira Pharma Presents Positive Data for NDX-1017 in Alzheimer's Patients at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference

Athira Pharma, Inc., a clinical-stage company developing innovative therapies focused on regeneration and recovery of brain function, today announced ...


07:52 ET Sheba Medical Center's Assistance Urgently Requested by World Health Organization (WHO) for Deadly Samoan Measles Outbreak

A team of medical experts from Israel's Sheba Medical Center, Tel HaShomer is embarking on an emergency deployment to the Pacific island nation of...


07:30 ET InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa

VANCOUVER, Dec. 9, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical stage...


07:30 ET Windtree Therapeutics Completes $26.4 Million Private Placement

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical...


07:30 ET Medicenna Announces Presentation of the MDNA55 Clinical Trial at the Inaugural Glioblastoma Drug Development Annual Summit

Presentation Will Provide Update on Survival Trends in Various Population Subgroups Medicenna to also Present at the LD Micro Investor Conference...


07:30 ET Advanced Wound Care Market to Reach $13.94 Bn, Globally, by 2026 at 6.5% CAGR: Allied Market Research

Allied Market Research published a report, titled, "Advanced Wound Care Market by Product (Infection Management, Exudate Management, Active Wound...


07:30 ET Global Surgical Robots Market Size was Estimated at USD 1190 Million in 2018, and is Expected to Grow USD 4270 Million by the end of 2025 at a CAGR of 20% | Valuates Reports™

As technological advances is all set to revolutionize healthcare in the years to come, the demand for surgical robots is expected to capture a...


07:30 ET Neurodiagnostics Market Worth $8.4 Billion by 2024 - Exclusive Report by MarketsandMarkets™

According to the new market research report "Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing...